LU73993A1 - - Google Patents

Info

Publication number
LU73993A1
LU73993A1 LU73993A LU73993A LU73993A1 LU 73993 A1 LU73993 A1 LU 73993A1 LU 73993 A LU73993 A LU 73993A LU 73993 A LU73993 A LU 73993A LU 73993 A1 LU73993 A1 LU 73993A1
Authority
LU
Luxembourg
Application number
LU73993A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU73993A1 publication Critical patent/LU73993A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
LU73993A 1974-12-13 1975-12-11 LU73993A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2458965A DE2458965C3 (de) 1974-12-13 1974-12-13 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
LU73993A1 true LU73993A1 (de) 1976-11-11

Family

ID=5933305

Family Applications (1)

Application Number Title Priority Date Filing Date
LU73993A LU73993A1 (de) 1974-12-13 1975-12-11

Country Status (27)

Country Link
US (1) US4051252A (de)
JP (1) JPS5182266A (de)
AT (1) AT343653B (de)
BE (1) BE836528A (de)
CA (1) CA1059523A (de)
CH (1) CH622250A5 (de)
CS (1) CS189731B2 (de)
DD (1) DD125484A5 (de)
DE (1) DE2458965C3 (de)
DK (1) DK137082C (de)
ES (1) ES443429A1 (de)
FI (1) FI753493A7 (de)
FR (1) FR2293928A1 (de)
GB (1) GB1490306A (de)
HK (1) HK52580A (de)
HU (1) HU173557B (de)
IE (1) IE42208B1 (de)
IL (1) IL48642A (de)
KE (1) KE3078A (de)
LU (1) LU73993A1 (de)
NL (1) NL7514521A (de)
NO (1) NO145382C (de)
PL (1) PL99858B1 (de)
SE (1) SE419645B (de)
SU (1) SU604487A3 (de)
YU (1) YU315275A (de)
ZA (1) ZA757777B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431657A (en) * 1982-05-24 1984-02-14 Ayerst, Mckenna & Harrison Inc. Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives
KR20010086657A (ko) * 2000-03-02 2001-09-15 성재갑 아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물
ATE346064T1 (de) 2000-09-15 2006-12-15 Vertex Pharma Pyrazolverbindungen als protein-kinasehemmer
US7473691B2 (en) * 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
ZA200301701B (en) * 2000-09-15 2004-03-01 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors.
SI1318997T1 (sl) * 2000-09-15 2006-12-31 Vertex Pharma Pirazolne spojine, uporabne kot inhibitorji protein-kinaze
WO2002068415A1 (en) 2000-12-21 2002-09-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
KR100406634B1 (ko) * 2001-03-12 2003-11-20 주식회사 엘지생명과학 3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도
PL368347A1 (en) 2001-09-26 2005-03-21 Pharmacia Italia S.P.A. Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
RU2004126671A (ru) * 2002-02-06 2005-04-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Гетероарилсоединения, полезные в качестве ингибиторов gsk-3
FR2836915B1 (fr) * 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US20040009981A1 (en) 2002-03-15 2004-01-15 David Bebbington Compositions useful as inhibitors of protein kinases
WO2003097610A1 (en) 2002-05-17 2003-11-27 Pharmacia Italia S.P.A. Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
MY141867A (en) * 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
JP4733388B2 (ja) 2002-08-02 2011-07-27 バーテックス ファーマシューティカルズ インコーポレイテッド Ｇｓｋ−３のインヒビターとして有用なピラゾール組成物
CA2502429A1 (en) * 2002-10-31 2004-05-21 Amgen Inc. Antiinflammation agents
US7601718B2 (en) 2003-02-06 2009-10-13 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
JP2007513184A (ja) * 2003-12-04 2007-05-24 バーテックス　ファーマシューティカルズ　インコーポレイテッド プロテインキナーゼのインヒビターとして有用なキノキサリン
DE102004005172A1 (de) 2004-02-02 2005-08-18 Aventis Pharma Deutschland Gmbh Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
EP1917259B1 (de) 2005-08-18 2012-01-25 Vertex Pharmaceuticals Incorporated Pyrazinkinaseinhibitoren
WO2007056163A2 (en) 2005-11-03 2007-05-18 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
US7847104B2 (en) * 2006-04-14 2010-12-07 Abbott Laboratories Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype1 (VR1) receptors
NZ576750A (en) 2006-11-02 2012-01-12 Vertex Pharma Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
AU2007333650A1 (en) 2006-12-19 2008-06-26 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
MX2009009592A (es) 2007-03-09 2009-11-10 Vertex Pharma Aminopiridinas utiles como inhibidores de proteinas cinasas.
WO2008112651A2 (en) 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
WO2008112642A1 (en) 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
AU2008240313A1 (en) 2007-04-13 2008-10-23 Aj Park Aminopyrimidines useful as kinase inhibitors
WO2008137622A2 (en) * 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
CN101801959A (zh) 2007-05-02 2010-08-11 沃泰克斯药物股份有限公司 可用作激酶抑制剂的氨基嘧啶类化合物
CN101679378A (zh) * 2007-05-02 2010-03-24 沃泰克斯药物股份有限公司 用作激酶抑制剂的噻唑和吡唑
CN101687852A (zh) * 2007-05-24 2010-03-31 沃泰克斯药物股份有限公司 可用作激酶抑制剂的噻唑类和吡唑类化合物
JP5553751B2 (ja) 2007-07-31 2014-07-16 バーテックス ファーマシューティカルズ インコーポレイテッド ５−フルオロ−１Ｈ−ピラゾロ［３，４−ｂ］ピリジン−３−アミンおよびその誘導体を調製するためのプロセス
WO2010027921A1 (en) * 2008-09-03 2010-03-11 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical formulations comprising the same
DE102009004245A1 (de) 2009-01-09 2010-07-15 Bayer Schering Pharma Aktiengesellschaft Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
HRP20180543T1 (hr) 2012-07-24 2018-06-29 Bial-Portela & Ca, S.A. Spojevi uree i njihova upotreba kao inhibitora enzima
JP2015528013A (ja) * 2012-07-27 2015-09-24 ビアル−ポルテラ エ コンパニア，ソシエダッド アノニマ 置換ウレア化合物の合成方法
CA2918993C (en) 2013-07-24 2021-08-24 Bial - Portela & Ca, S.A. Imidazolecarboxamides and their use as faah inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133081A (en) * 1964-05-12 J-aminoindazole derivatives
CH397698A (de) * 1961-09-08 1965-08-31 Siegfried Ag Verfahren zur Herstellung neuer 1-Carbamyl-indazole
US3277100A (en) * 1963-05-31 1966-10-04 Du Pont Novel substituted pyrazoles
NL6707299A (de) * 1966-07-16 1968-01-17
DE1770649A1 (de) * 1968-06-15 1971-11-11 Bayer Ag Substituierte 3-Amino-indazole

Also Published As

Publication number Publication date
FI753493A7 (de) 1976-06-14
AT343653B (de) 1978-06-12
CS189731B2 (en) 1979-04-30
SE419645B (sv) 1981-08-17
US4051252A (en) 1977-09-27
BE836528A (fr) 1976-06-11
SE7513990L (sv) 1976-06-14
PL99858B1 (pl) 1978-08-31
ES443429A1 (es) 1977-04-16
FR2293928B1 (de) 1979-09-21
DK137082B (da) 1978-01-16
CH622250A5 (de) 1981-03-31
NO145382B (no) 1981-11-30
NO145382C (no) 1982-03-10
IL48642A0 (en) 1976-02-29
IL48642A (en) 1979-12-30
YU315275A (en) 1982-02-28
DD125484A5 (de) 1977-04-20
DE2458965B2 (de) 1979-02-22
ZA757777B (en) 1976-11-24
DK137082C (da) 1978-06-19
DE2458965C3 (de) 1979-10-11
JPS5182266A (en) 1976-07-19
DK567275A (da) 1976-06-14
SU604487A3 (ru) 1978-04-25
IE42208B1 (en) 1980-06-18
HU173557B (hu) 1979-06-28
DE2458965A1 (de) 1976-06-16
HK52580A (en) 1980-09-26
CA1059523A (en) 1979-07-31
NO754024L (de) 1976-06-15
AU8717075A (en) 1977-06-09
IE42208L (en) 1976-06-13
ATA939775A (de) 1977-10-15
KE3078A (en) 1980-10-03
NL7514521A (nl) 1976-06-15
GB1490306A (en) 1977-11-02
FR2293928A1 (fr) 1976-07-09

Similar Documents

Publication Publication Date Title
FI750774A7 (de)
FI751816A7 (de)
DK137073C (de)
DK277975A (de)
FI750845A7 (de)
FI751964A7 (de)
FI751935A7 (de)
FI751156A7 (de)
FR2258801A1 (de)
FI752657A7 (de)
DK104775A (de)
FR2256731B1 (de)
DK135346C (de)
DK335075A (de)
DK432975A (de)
CS167832B1 (de)
CS168343B1 (de)
CS169268B1 (de)
CS171460B1 (de)
CS171573B1 (de)
CS172644B1 (de)
CS173829B1 (de)
CS177536B1 (de)
CS166115B1 (de)
CS165765B1 (de)